Angiotensin News and Research

RSS
Angiotensin is an oligopeptide in the blood that causes vasoconstriction, increased blood pressure, and release of aldosterone from the adrenal cortex. It is a powerful dipsogen. It is derived from the precursor molecule angiotensinogen, a serum globulin produced in the liver. It plays an important role in the renin-angiotensin system.
Scientists identify new drug target for potential blood pressure treatment

Scientists identify new drug target for potential blood pressure treatment

D-serine produced by gut microbiota protects against acute kidney injury, show study

D-serine produced by gut microbiota protects against acute kidney injury, show study

Heart failure patients with stronger hearts have more depressive symptoms, lower quality of life

Heart failure patients with stronger hearts have more depressive symptoms, lower quality of life

Angiotensin receptor blockers improve sodium excretion in blacks

Angiotensin receptor blockers improve sodium excretion in blacks

Newly designed mice emulate severe form of kidney damage in humans with diabetes

Newly designed mice emulate severe form of kidney damage in humans with diabetes

Common biomarker of kidney disease may also indicate COPD

Common biomarker of kidney disease may also indicate COPD

New statement provides detailed overview of how to diagnose, treat resistant hypertension

New statement provides detailed overview of how to diagnose, treat resistant hypertension

Blood pressure lowering therapy and statins continue to improve survival in patients with hypertension

Blood pressure lowering therapy and statins continue to improve survival in patients with hypertension

Blood pressure medication slows enlargement of the aorta in patients with Marfan syndrome

Blood pressure medication slows enlargement of the aorta in patients with Marfan syndrome

Taking vacations could prolong life, suggests new study

Taking vacations could prolong life, suggests new study

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

Plant-based products fail to have positive impact on blood pressure during clinical studies

Plant-based products fail to have positive impact on blood pressure during clinical studies

Non-opioid drug shows promise for treating pain by targeting receptors on immune cells

Non-opioid drug shows promise for treating pain by targeting receptors on immune cells

Study suggests proteinuria lowering as important target in managing pediatric CKD

Study suggests proteinuria lowering as important target in managing pediatric CKD

Fewer women meet eligibility criteria for clinical trial of heart failure drugs, study finds

Fewer women meet eligibility criteria for clinical trial of heart failure drugs, study finds

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

UH professor receives NIH grant to protect kidneys from obesity

UH professor receives NIH grant to protect kidneys from obesity

Experimental compound reduces destructive inflammation to improve stroke outcome

Experimental compound reduces destructive inflammation to improve stroke outcome

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.